Legal status · United States
Is Abaloparatide legal in the United States?
Yes. Abaloparatide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Abaloparatide in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| FDA approval status | FDA-approved (Tymlos) for osteoporosis |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Abaloparatide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Abaloparatide for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Abaloparatide is
An FDA-approved bone-building peptide analogue of parathyroid hormone-related protein for postmenopausal osteoporosis.
Abaloparatide is a synthetic analogue of parathyroid hormone-related protein, approved as Tymlos to build bone in postmenopausal women at high fracture risk. Like teriparatide it stimulates new bone formation with once-daily injection, and trials showed strong fracture reduction.
Mechanism: Selectively activates the PTH1 receptor to favor bone formation over resorption, increasing bone density.
Regulatory history: FDA-approved (Tymlos) for osteoporosis
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Abaloparatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Abaloparatide in other countries
United Kingdom
Approved medicineLicensed, prescription only (MHRA)
Is Abaloparatide legal in the United Kingdom?Australia
Approved medicineTGA-registered, prescription only
Is Abaloparatide legal in Australia?Canada
Approved medicineHealth Canada approved, prescription only
Is Abaloparatide legal in Canada?Frequently asked questions
Is Abaloparatide legal in the United States?
Yes. Abaloparatide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Abaloparatide in the United States?
Only with a prescription. Abaloparatide is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Abaloparatide FDA approved?
Yes. FDA status: FDA-approved (Tymlos) for osteoporosis. Current US classification: "FDA-approved, prescription only". Evidence level: Strong.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Abaloparatide live on its compound profile.
Abaloparatide profileThis page is general information about the regulatory status of Abaloparatide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.